News
Public · Published
Piper Sandler maintains Inspire Medical Systems at Neutral, raises price target to $70 from $60
Piper Sandler kept its Neutral rating on Inspire Medical Systems and raised its price target to $70 from $60, a 16.7% increase. That target implies 4.2% upside from the Nov 2 close of $67.21.
Published:
Updated:
What happened
Piper Sandler kept its Neutral rating on Inspire Medical Systems and raised its price target to $70 from $60, a 16.7% increase. That target implies 4.2% upside from the Nov 2 close of $67.21.
Confirmed
Global impact / market context
A higher target means Piper Sandler sees more value per share, yet Neutral signals no strong buy call. The small implied upside suggests the stock already trades near that target, so Piper Sandler expects limited extra return from here.
Analyst inference
Price targets from recent analyst notes range from $65 to $78, so Piper Sandler's $70 sits in the middle. That spread shows divided views on Inspire Medical Systems, and the Neutral rating suggests analysts see the shares as fairly priced rather than cheap.
Analyst inference
What to watch
- Piper Sandler's $70 target implies 4.2% upside from the Nov 2 close of $67.21, so watch whether the shares move toward or past that target level. Confirmed
- Watch for further analyst notes, because recent price targets range from $65 to $78; a shift toward the high or low end would signal changing views on the company. Analyst inference
- Watch whether Inspire Medical Systems reports sales and profit that justify a higher value, since Neutral ratings often persist until results show clearer growth. Proposed
Evidence
- Original source link unavailable